Boltz raises $110M Series A for AI biomolecular design, partners with 6 of top 20 pharmas
GabriCorso · x · 2026-11-19
AI biomolecular design startup Boltz announced a $110M Series A led by Bessemer Venture Partners.
Key numbers:
- 100K+ scientists use Boltz's models
- Paying customers' molecular token usage has grown 50x since June
- 6 of the world's 20 largest pharma companies have partnered with the startup
Boltz aims to bring AI-powered biomolecular design to every scientist.
More from Venture
- Palo Alto Networks buys OpenAI-alumni startup Applied Compute for $4.5B — KateClarkTweets · 2026-11-19
- Nvidia Allegedly Made GPUs Artificially Scarce to Keep Prices Sky-High — GaryMarcus · 2026-11-19
- marclou launches $100K hackathon: build a profitable startup in 30 days — marclou · 2026-11-19
- Replit launches Co., a creator program for people turning expertise into tools and businesses — amasad · 2026-11-19
- Nvidia chair rules out Jensen Huang return as 200,000-signature petition mounts — ivan_bezdomny · 2026-11-19
- Open-source project with $10/month pricing crosses $1M ARR, defying early skepticism — ycombinator · 2026-11-19